Cargando…
Preliminary results of a vaginal constraint for reducing G2 late vaginal complications after postoperative brachytherapy in endometrial cancer: a prospective analysis
PURPOSE: To evaluate the preliminary results of the use of 68 Gy EQD2((α/β=3 Gy)) as a dose limit to the lowest dose in the most exposed 2 cm(3) of the vagina in order to reduce G2 late vaginal problems in postoperative endometrial carcinoma (EC). METHODS: From November 2016 to October 2019, 69 post...
Autores principales: | Zhang, Y., Gomez, G., Ascaso, C., Herreros, A., Fornes, B., Mases, J., Rochera, J., Tagliaferri, L., Sabater, S., Torne, A., Biete, A., Rovirosa, Á. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013320/ https://www.ncbi.nlm.nih.gov/pubmed/34854030 http://dx.doi.org/10.1007/s12094-021-02737-z |
Ejemplares similares
-
EQD2 Analyses of Vaginal Complications in Exclusive Brachytherapy for Postoperative Endometrial Carcinoma
por: Zhang, Yaowen, et al.
Publicado: (2020) -
Vaginal dilator use more than 9 months is a main prognostic factor for reducing G2‑late vaginal complications in 3D‑vaginal‑cuff brachytherapy (interventional radiotherapy)?
por: Zhang, Yaowen, et al.
Publicado: (2023) -
Vaginal cuff brachytherapy in endometrial cancer – a technically easy treatment?
por: Sabater, Sebastià, et al.
Publicado: (2017) -
Body Mass Index and Doses at Organs at Risk in a Mediterranean Population Treated with Postoperative Vaginal Cuff Brachytherapy
por: Sabater, Sebastia, et al.
Publicado: (2015) -
EROS 2.0 study: evaluation of two interventional radiotherapy (brachytherapy) schedules for endometrial cancer: a comparison of late vaginal toxicity rates
por: Lancellotta, Valentina, et al.
Publicado: (2022)